ImageBiopsy Lab

17/09/2021

We are happy to announce that Dr. Jack Farr has joined ImageBiopsy Lab's US Medical Advisory Board. With this significant addition, we are further strengthening our close collaboration with leading US orthopedic surgeons and MSK radiologists.

Dr. Farr received his medical degree from Indiana University in 1979 and completed his orthopedic surgery residency at Indiana University Medical Center in 1986. Since then, he became a leader in U.S. cartilage restoration advances and has written many medical articles, book chapters, as well as two cartilage books. Dr. Farr specializes in knee surgery, cartilage restoration, partial joint replacement, and sports medicine, and it is actively affiliated with OrthoIndy Hospital and Community Hospital South. He is a member of various American and International medical societies such as the American Academy of Orthopaedic Surgeons, the American Orthopaedic Society of Sports Medicine, and the International Cartilage Repair Society.

Great to have you onboard Jack!

16/09/2021

We are thrilled to have yet another leading German university hospital to commercially deploy our -AI software. Big shout out to our DACH key account team to sign a commercial partnership with Ludwig-Maximilians-Universität München Clinic, one of the largest university hospitals in Germany and Europe.

Our MSK AI-driven software applications will be used in clinical routine to support and automate the of pediatric radiologists and orthopedists.

This is yet another significant success for the ImageBiopsy Lab team & we are looking forward to working together on our way to digital MSK diagnostics!

10/09/2021

We want to welcome Eleanor Barnes, our Junior Research Specialist!
Eleanor studied Biology at Oxford University and has additional training in computational biology. She has experience within the UK National Health Service, working with national and regional patient-level healthcare data to perform data analysis and data science. Her professional interests are around the application of technology, AI, and data analysis in improving healthcare patients. "After all, we are all patients at some point", — she says. In her free time, she practices contemporary dance, which she finds really enjoyable! She also loves to be outside in nature and green spaces.

Happy to have you onboard, Eleanor!

08/09/2021

AI - is a new big word in medicine! ImageBiopsy Lab is proud to be a pioneer in bringing AI-based software to radiologists and orthopedists. Since we released our first product in 2019, more than 150 sites have been successfully using our products. Thank you, Radiologie Magazin for featuring us!


See also all featured products: https://lnkd.in/eRaXzKeQ

Das Wiener Tech-Startup ImageBiopsy Lab hat dafür eine auf Künstlicher Intelligenz (KI) basierte Software entwickelt, die Muskel-Skelett (MSK) Bilddaten nahezu in Echtzeit analysiert und subjektive Fehler der Berhandler:Innen ausschließt.

02/09/2021

Heads up! ImageBiopsy Lab is happy to announce its' recently signed commercial partnership with Inselspital Bern, one of the leading orthopedic university hospitals in Switzerland. Our IB Lab HIPPO -AI module will be integrated into the existing clinical workflows to support as well as in their image analysis routine. Congratulations to our Swiss sales team for this significant milestone! Go Switzerland!

25/08/2021

Is artificial intelligence (AI) a new magic word for radiology?

Often, radiologists are overwhelmed with hundreds of X-ray images they have to read every day, facing a difficult decision on which radiograph to look at first and which bone disease is more severe or in the worse stage. At ImageBiopsy Lab, we developed AI-driven software applications that help radiologists optimize their time and workflow by providing automated, more accurate, and standardized medical reports.

Our CEO & Co-founder, Richard Ljuhar, has given an interview for Handelsblatt (article in German) telling our vision and presenting ImageBiopsy Lab's new dimension of MSK imaging diagnostics.

Click here & read the article yourself!
https://zurl.co/bcKI

Die Analyse von Röntgenbildern ist aufwendig und fehleranfällig. Ein Algorithmus des Wiener Jungunternehmens Imagebiopsy soll helfen.

24/08/2021

We are proud to work with Alma Medical Imaging, expanding our footprint in Europe and enabling radiologists and orthopedists in Spain to integrate our AI-driven software solutions into their clinical workflow.

ImageBiopsy Lab, your tool for image diagnosis in musculoskeletal .

✅ Analyse hip positioning and pelvic morphology.
✅ Measure radiographic signs of knee osteoarthritis.
✅ Detect knee alignment deformities.
✅ Assess conditions that can affect the growth of children.

Contact us for more information! 👉 https://bit.ly/3B6Q2DO

11/08/2021

A new dimension of Musculoskeletal (MSK) imaging diagnostics - ImageBiopsy Lab. We are excited to announce that we have launched our new Website! You'll be able to find out more information about our products as well as our team and partnerships. Check it out here:

AI-based solutions reduce the amount of work and the findings become more accurate. An objective value is given which can be used both for monitoring and forecasting the progress. We offer something that others don’t have.

23/07/2021

ImageBiopsy Lab gehöhrt zu den führenden Anbietern für KI-unterstützte Analyse in der muskuloskelettalen und orthopädischer Bildgebung (MSK). Unsere in Zusammenarbeit mit Fachärzten aufgebaute KI-gestützte Softwareplattform ist eine Möglichkeit, um die komplexe Diagnostik der muskuloskelettalen Radiologie, Orthopädie und Traumatologie zu unterstützen.

Danke Healthcare Computing. Lesen Sie hier den ganzen Artikel: https://www.healthcare-computing.de/knochenleser-kuenstliche-intelligenz-soll-geruest-und-gelenkerkrankungen-erkennen-a-1039151/?cmp=nl-443&uuid=2e065da588b334633c9341111f67aee4

Probieren Sie unsere Software: https://lnkd.in/dkVKn-i

Mehr als zehn Millionen radiologische Aufnahmen aus fünf Ländern flossen in einen KI-Algorithmus, um Knochen- und Gelenkerkrankungen zu diagnostizieren. Ein Start-up hat bereits nach fünf Jahren eine Zulassung in Europa und den USA. Neue Anwendungen sind geplant.